Pancreatic Cancer Clinical Trials

Showing 701-720 of 1,185 trials

Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma

NCT01219829

The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.

Pancreatic Cancer

Columbia University5 participantsStarted Mar 2009

New York, New York, United States

COMPLETEDPhase 2

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

NCT00031694

Phase II trial to study the effectiveness of combining paclitaxel and bryostatin-1 in treating patients who have locally advanced unresectable or metastatic pancreatic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bryostatin-1 may help paclitaxel kill more cancer cells by making tumor cells more sensitive to the drug.

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more

National Cancer Institute (NCI)19 participantsStarted Mar 2002

The Bronx, New York, United States

COMPLETEDNA

Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer

NCT01027221

Principal purpose of the study is the determination of an active local external beam radiotherapy dose leading to a maximum number of tumor infiltrating T-cells.

Primarily Resectable Pancreatic Cancer

German Cancer Research Center32 participantsStarted Nov 2009

Heidelberg, Germany • Heidelberg, Germany

Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer

Related Searches

Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular Pancreatosplenectomy

BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

Metformin Combined With Chemotherapy for Pancreatic Cancer

Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer

Preoperative Biliary Drainage in Malignant Biliary Obstruction

Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas

Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma

An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)

Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials